Novel Anti-inflammatory Agents Based on Pyrazole Based Dimeric Compounds; Design, Synthesis, Docking and in Vivo Activity

被引:57
作者
Tewari, Ashish Kumar [1 ]
Srivastava, Priyanka [1 ]
Singh, Ved Prakash [1 ]
Singh, Amit [2 ]
Goel, Raj Kumar [2 ]
Mohan, Chethampadi Gopi [3 ]
机构
[1] Banaras Hindu Univ, Fac Sci, Dept Chem, Varanasi 221005, Uttar Pradesh, India
[2] Banaras Hindu Univ, Dept Pharmacol, IMS, Varanasi 221005, Uttar Pradesh, India
[3] NIPER, Ctr Pharmacoinformat, Sas Nagar 160062, Punjab, India
关键词
prodrug; pyrazole; cyclooxygenase; docking; NMR; SELECTIVE INHIBITORS; GENERAL-SYNTHESIS; COX-2; INHIBITORS; CYCLOOXYGENASE; DRUGS; FUTURE;
D O I
10.1248/cpb.58.634
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Series of pyrazole ester prodrugs analogues have been synthesized and found to contain highly potent inhibitors of the cyclooxygenase-2 (COX-2) enzyme. The paper describes synthesis of the target pyrazole analogues. The structure of the synthesized mutual ester prodrugs (6-8c) were confirmed by H-1-, C-13-NMR mass spectroscopy (MS) and their purity were ascertained by TLC and elemental analyses. The biological in vivo evaluation of these compounds in experimental models (carrageenan-induced oedema) proved the presence of anti-inflammatory activity. Docking studies into the catalytic site of COX-2 were used to identify potential anti-inflammatory lead compounds. One lead derivative was chosen endowed with good binding energies.
引用
收藏
页码:634 / 638
页数:5
相关论文
共 28 条
[1]   Synthesis and structure -: Activity relationship of a new series of COX-2 selective inhibitors:: 1,5-diarylimidazoles [J].
Almansa, C ;
Alfón, J ;
de Arriba, AF ;
Cavalcanti, FL ;
Escamilla, I ;
Gómez, LA ;
Miralles, A ;
Soliva, R ;
Bartrolí, J ;
Carceller, E ;
Merlos, M ;
García-Rafanell, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (16) :3463-3475
[2]  
AMADIO P, 1993, POSTGRAD MED, V93, P73
[3]  
Amir M, 2005, INDIAN J CHEM B, V44, P2532
[4]  
APPARAO S, 1981, SYNTHESIS-STUTTGART, P65
[5]   Structural and functional basis of cyclooxygenase inhibition [J].
Blobaum, Anna L. ;
Marnett, Lawrence J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) :1425-1441
[6]   Inhibitors of cyclooxygenase-2: November 1999-April 2000 [J].
Carter, JS .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (07) :1011-1020
[7]   KETENE-S,S-ACETALS .5. REACTIONS OF ALPHA-KETO AND ALPHA-CYANOKETENE-S,S-ACETALS WITH GUANIDINE AND THIOUREA - NEW GENERAL SYNTHESIS OF ALKOXY-PYRIMIDINES [J].
CHAUHAN, SMS ;
JUNJAPPA, H .
TETRAHEDRON, 1976, 32 (14) :1779-1787
[8]   Structural approaches to explain the selectivity of COX-2 inhibitors: Is there a common pharmacophore? [J].
Dannhardt, G ;
Laufer, S .
CURRENT MEDICINAL CHEMISTRY, 2000, 7 (11) :1101-1112
[9]   Cyclooxygenase inhibitors - current status and future prospects [J].
Dannhardt, G ;
Kiefer, W .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (02) :109-126
[10]  
Donge JM, 2005, J MED CHEM, V48, P2251